Send to

Choose Destination
Diagn Microbiol Infect Dis. 2012 Mar;72(3):248-52. doi: 10.1016/j.diagmicrobio.2011.11.008. Epub 2012 Jan 17.

Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City.

Author information

Infectious Disease Section, New York Hospital Queens, Flushing, NY 11355, USA.


We have identified CTX-M group 1 β-lactamases in 87% of community-acquired Escherichia coli isolates that produce extended-spectrum β-lactamases, with the majority harboring CTX-M-15 and representing the ST131 clonal group. Seventy percent of CTX-M-bearing isolates were from urine specimens; a large proportion was nonsusceptible to levofloxacin, trimethoprim/sulfamethoxazole, and β-lactam antimicrobials. Many patients were relatively youthful (41% ≤65 years old; youngest, age 32). Patients with symptomatic bacteriuria received drugs to which the organisms were susceptible, and most had favorable outcomes. Timely recognition of such isolates could help physicians choose more appropriate antibacterial therapy.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center